Rapha Capital Management, LLC
Rapha Capital Management, LLC is a venture capital firm focused on identifying and nurturing revolutionary ideas in medicine, healthcare, and technology. Founded in mid-2018, the firm aims to discover and support companies at the earliest stages that have the potential to significantly improve people's lives and create substantial value. Rapha Capital manages 13 entities, Rapha Capital Investment I – XIII, and is committed to leveraging its unique abilities to identify promising opportunities in a sea of less compelling options.
Rapha Capital Management, LLC
Portfolio
3DBio Therapeutics is advancing therapeutic-grade bioprinting to manufacture living tissues designed for individual patients. The company focuses on craniofacial and spinal cartilage applications.
#Bioprinting and Regenerative Medicine
angelMD is a platform connecting medical startups with physicians and investors.
#Healthcare Investment Platform
AsclepiX Therapeutics focuses on developing novel peptide therapies for retinal diseases.
#Biopharmaceuticals
Bellicum is a leader in developing controllable cellular immunotherapies for cancers and orphan inherited blood disorders.
#Biopharmaceuticals
ControlRad focuses on reducing radiation exposure during medical imaging procedures.
#Medical Devices
DELiver Therapeutics is involved in developing targeted drug delivery systems.
#Biopharmaceuticals
Demeetra Agbio focuses on developing sustainable agricultural solutions.
#Agricultural Biotechnology
FIZE Medical is innovating in fluid management technology, having secured $30 million in Series A funding.
#Medical Devices
IMAGIN Medical is developing advanced imaging solutions for early cancer detection.
#Medical Devices
NexImmune is developing nanoparticle-based immunotherapies to enhance T cell responses against cancer.
#Biopharmaceuticals
NuMat Technologies focuses on molecularly engineered products for gas storage and delivery.
#Advanced Materials
Ponce Therapeutics is developing therapies for age-related diseases.
#Biopharmaceuticals
Poseida is developing CAR-T cell therapies for multiple myeloma and other cancers, with a focus on gene engineering technologies.
#Biotechnology
Sightly focuses on brand safety and video advertising solutions, achieving over 99% in IAS YouTube brand safety measurement.
#Digital Media